Sender R, Bar-On YM, Gleizer S, Bernshtein B, Flamholz A, Phillips R, Milo R. The total number and mass of SARS-CoV-2 virions. Proc Natl Acad Sci U S A. 2021;118:e2024815118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng SMS, Mok CKP, Leung YWY, Ng SS, Chan KCK, Ko FW, Chen C, Yiu K, Lam BHS, Lau EHY, et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nat Med. 2022;28:486–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arora P, Zhang L, Krüger N, Rocha C, Sidarovich A, Schulz S, Kempf A, Graichen L, Moldenhauer AS, Cossmann A, et al. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies. Cell Host Microbe. 2022;30:1103–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans JP, Zeng C, Qu P, Faraone J, Zheng YM, Carlin C, Bednash JS, Zhou T, Lozanski G, Mallampalli R, et al. Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2. Cell Host Microbe. 2022;30:1093–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, Liu C, Mentzer AJ, Supasa P, Duyvesteyn HME, et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422-2433.e2413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, Le KC, Wrapp D, Lee AG, Liu Y, et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science. 2020;369:1501–5.

Article  CAS  PubMed  Google Scholar 

Dejnirattisai W, Huo J, Zhou D, Zahradnik J, Supasa P, Liu C, Duyvesteyn HME, Ginn HM, Mentzer AJ, Tuekprakhon A, et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185:467-484 e415.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou H, Dcosta BM, Landau NR, Tada T. Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 variants to vaccine-elicited sera and therapeutic monoclonal antibodies. Viruses. 2022;14:1334.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohashi H, Hishiki T, Akazawa D, Kim KS, Woo J, Shionoya K, Tsuchimoto K, Iwanami S, Moriyama S, Kinoshita H, et al. Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2. Antiviral Res. 2022;205:105372.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O’Connell AM, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386:1532–46.

Article  CAS  PubMed  Google Scholar 

Cao Y, Wang X, Li S, Dong Y, Liu Y, Li J, Zhao Y, Feng Y. A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial. Sci China Life Sci. 2022;65:1677–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arora P, Kempf A, Nehlmeier I, Schulz SR, Cossmann A, Stankov MV, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5. Lancet Infect Dis. 2022;22:1117–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurhade C, Zou J, Xia H, Cai H, Yang Q, Cutler M, Cooper D, Muik A, Jansen KU, Xie X, et al. Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. Nat Commun. 2022;13:3602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurhade C, Zou J, Xia H, Liu M, Yang Q, Cutler M, Cooper D, Muik A, Sahin U, Jansen KU, et al. Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection. Emerg Microbes Infect. 2022;11:1828–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, Cele S, Lustig G, Amoako D, Wolter N, et al. Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity. medRxiv. 2022. https://doi.org/10.1101/2022.04.29.22274477.

Article  PubMed  PubMed Central  Google Scholar 

Davies MA, Morden E, Rosseau P, Arendse J, Bam JL, Boloko L, Cloete K, Cohen C, Chetty N, Dane P, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. medRxiv. 2022. https://doi.org/10.1101/2022.06.28.22276983.

Article  PubMed  PubMed Central  Google Scholar 

Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608:593–602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, et al. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Rep Med. 2022;3:100679.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng B, Gao L, Zhou Q, Yu K, Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2022;20:200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao KM, Tzou PL, Pond SLK, Ioannidis JPA, Shafer RW. Susceptibility of SARS-CoV-2 omicron variants to therapeutic monoclonal antibodies: systematic review and meta-analysis. Microbiol Spectr. 2022;10(4):e00926-22.

Article  PubMed  PubMed Central  Google Scholar 

Bowen JE, Sprouse KR, Walls AC, Mazzitelli IG, Logue JK, Franko NM, Ahmed K, Shariq A, Cameroni E, Gori A, et al. Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines. bioRxiv. 2022. https://doi.org/10.1101/2022.03.15.484542.

Article  PubMed  PubMed Central  Google Scholar 

Hachmann NP, Miller J, Collier AY, Ventura JD, Yu JY, Rowe M, Bondzie EA, Powers O, Surve N, Hall K, Barouch DH. Neutralization escape by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387:86–8.

Article  PubMed  Google Scholar 

Kawaoka Y, Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann P, Loeber S, Maemura T, et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Res Sq. 2022. https://doi.org/10.21203/rs.3.rs-1375091/v1.

Article  PubMed  PubMed Central  Google Scholar 

Park YJ, Pinto D, Walls AC, Liu Z, De Marco A, Benigni F, Zatta F, Silacci-Fregni C, Bassi J, Sprouse KR, et al. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science. 2022;378:619–27.

Article  CAS  PubMed  Google Scholar 

Pedersen RM, Bang LL, Madsen LW, Sydenham TV, Johansen IS, Jensen TG, Justesen US, Andersen TE. Serum neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 booster vaccination. Emerg Infect Dis. 2022;28:1274–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qu P, Faraone J, Evans JP, Zou X, Zheng YM, Carlin C, Bednash JS, Lozanski G, Mallampalli RK, Saif LJ, et al. Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 subvariants. N Engl J Med. 2022;386:2526–8.

Article  PubMed  Google Scholar 

Qu P, Faraone JN, Evans JP, Zheng YM, Carlin C, Lozanski G, Saif LJ, Oltz EM, Gumina RJ, Liu SL. Durability of the neutralizing antibody response to mRNA booster vaccination against SARS-CoV-2 BA.2.12.1 and BA4/5 variants. bioRxiv. 2022. https://doi.org/10.1101/2022.07.21.501010.

Article  PubMed  PubMed Central  Google Scholar 

Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Schmitz KS, Geers D, Bogers S, van Haren E, Koopmans MPG, et al. Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers. Clin Infect Dis. 2022. https://doi.org/10.1093/cid/ciac495.

Article  PubMed Central  Google Scholar 

Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, Cantoni D, Scott S, Logan N, Ashraf S, et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7:1161–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willett BJ, Kurshan A, Thakur N, Newman J, Manali M, Tyson G, Logan N, Murcia PR, Snell LB, Edgeworth JD, et al. Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5. bioRxiv. 2022. https://doi.org/10.1101/2022.05.25.493397

Article  Google Scholar 

Yu J, Collier ARY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 variants. N Engl J Med. 2022;386:1579–81.

Article  PubMed  Google Scholar 

Zhou R, Liu N, Li X, Peng Q, Yiu CK, Huang H, Yang D, Du Z, Kwok HY, Au KK, et al. Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron-BA.2. bioRxiv. 2022. https://doi.org/10.1101/2022.0